NCT01332279 2023-04-04
Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy
Fox Chase Cancer Center
Phase 1 Withdrawn
Fox Chase Cancer Center
University of Pittsburgh
GERCOR - Multidisciplinary Oncology Cooperative Group
Emory University
Dana-Farber Cancer Institute
University College, London